The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study

• Published in: The Journal of urology Vol. 156; no. 5; p. 1631
• Main Authors: Kara, H, Aydin, S, Yücel, M, Agargün, M Y, Odabaş, O, Yilmaz, Y
• Format: Journal Article
• Language: English
• Published: United States 01-11-1996
• Subjects: Adolescent; Adult; Double-Blind Method; Ejaculation - drug effects; Fluoxetine - therapeutic use; Humans; Male; Middle Aged; Serotonin Uptake Inhibitors - therapeutic use; Time Factors
• ISSN: 0022-5347
• DOI: 10.1016/S0022-5347(01)65467-3

The efficacy of the selective serotonin re-uptake inhibitor fluoxetine in the treatment of premature ejaculation was examined.
The study comprised 17 patients with premature ejaculation who presented to the urology clinic of our medical school. In this double-blind study the patients were randomized into treatment groups receiving 20 mg. fluoxetine daily for 1 week and 40 mg. daily afterward (group 1) or 1 capsule placebo daily for 1 week and 2 capsules daily afterward (group 2). The groups were evaluated according to the latent period of intravaginal ejaculation.
The latent period of intravaginal ejaculation in group 1 was significantly longer than that in group 2. Nausea, headache and insomnia were reported side effects.
Fluoxetine may be regarded as a safe and effective alternative in the treatment of premature ejaculation.